Genetic influences on individual differences in nicotine glucuronidation

Twin Research and Human Genetics

Volumn 12, Issue 5, 2009, Pages 507-513

  Lessov Schlaggar, Christina N ^a   Benowitz, Neal L ^b,c   Jacob III, Peyton ^b   Swan, Gary E ^d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SRI INTERNATIONAL   (United States)

Author keywords

Glucuronidation; Heritability; Nicotine metabolism; Twins

Indexed keywords

3' HYDROXYCOTININE; COTININE; GLUCURONOSYLTRANSFERASE; NICOTINE; GLUCURONIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; DIZYGOTIC TWINS; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG URINE LEVEL; ENVIRONMENTAL FACTOR; FEMALE; GLUCURONIDATION; HEREDITY; HUMAN; HUMAN EXPERIMENT; KIDNEY CLEARANCE; MALE; MONOZYGOTIC TWINS; NORMAL HUMAN; PRIORITY JOURNAL; COMPARATIVE STUDY; GENE FREQUENCY; GENETICS; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; TWINS;

ADULT; COTININE; FEMALE; GENE FREQUENCY; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; NICOTINE; TWINS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 74949120445     PISSN: 18324274     EISSN: None     Source Type: Journal    
DOI: 10.1375/twin.12.5.507     Document Type: Article

References (19)

1. Akaike, H. (1987). Factor analysis and AIC. Psychometrika, 52, 317-332.
2. Argikar, U. A., Iwuchukwu, O. F., & Nagar, S. (2008). Update on tools for evaluation of uridine diphosphoglucuronosyltransferase polymorphisms. Expert Opinion on Drug Metabolism & Toxicology, 4, 879-894.
3. Benowitz, N. L., Jacob, P., 3rd, Fong, I., & Gupta, S. (1994). Nicotine metabolic profile in man: Comparison of cigarette smoking and transdermal nicotine. Journal of Pharmacology & Experimental Therapeutics, 268, 296-303.
4. Benowitz, N. L., Lessov-Schlaggar, C. N., & Swan, G. E. (2008). Genetic influences in the variation in renal clearance of nicotine and cotinine. Clinical Pharmacology & Therapeutics, 84, 243-247.
5. Benowitz, N. L., Lessov-Schlaggar, C. N., Swan, G. E., & Jacob, P., 3rd. (2006). Female sex and oral contraceptive use accelerate nicotine metabolism. Clinical Pharmacology & Therapeutics, 79, 480-488.
6. Benowitz, N. L., Swan, G. E., Jacob, P., 3rd, Lessov-Schlaggar, C. N., & Tyndale, R. F. (2006). CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Clinical Pharmacology & Therapeutics, 80, 457-467.
7. Byrd, G. D., Chang, K. M., Greene, J. M., & deBethizy, J. D. (1992). Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3′-hydroxycotinine in smokers. Drug Metabolism and Disposition, 20, 192-197.
8. Chen, G., Blevins-Primeau, A. S., Dellinger, R. W., Muscat, J. E., & Lazarus, P. (2007). Glucuronidation of nicotine and cotinine by UGT2B10: Loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism. Cancer Research, 67, 9024-9029.
9. Ehmer, U., Vogel, A., Schutte, J. K., Krone, B., Manns, M. P., & Strassburg, C. P. (2004). Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology, 39, 970-977.
10. Ghosheh, O., & Hawes, E. M. (2002). N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases. Drug Metabolism and Disposition, 30, 991-996.
11. Hukkanen, J., Jacob, P., 3rd, & Benowitz, N. L. (2005). Metabolism and disposition kinetics of nicotine. Pharmacological Reviews, 57, 79-115.
12. Kaivosaari, S., Toivonen, P., Hesse, L. M., Koskinen, M., Court, M. H., & Finel, M. (2007). Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10. Molecular Pharmacology, 72, 761-768.
13. Kuehl, G. E., & Murphy, S. E. (2003). N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases. Drug Metabolism and Disposition, 31, 1361-1368.
14. Nakajima, M., Yamamoto, T., Nunoya, K., Yokoi, T., Nagashima, K., Inoue, K., Funae, Y., Shimada, N., Kamataki, T., & Kuroiwa, Y. (1996). Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. Journal of Pharmacology & Experimental Therapeutics, 277, 1010-1015.
15. Neale, M. C., M., B. S., Xie, G., & Maes, H. H. (2002). Mx: Statistical modeling (6th ed.). VCU Box 900126, Richmond, VA 23298: Department of Psychiatry.
16. StataCorp. (2005). Stata Statistical Software Release 9 (Version Release 9). College Station, TX: Stata Corporation.
17. Swan, G. E., Benowitz, N. L., Jacob, P., 3rd, Lessov, C. N., Tyndale, R. F., Wilhelmsen, K., Krasnow, R. E., McElroy, M. R., Moore, S. E., & Wambach, M. (2004). Pharmacogenetics of nicotine metabolism in twins: Methods and procedures. Twin Research, 7, 435-448.
18. Swan, G. E., Benowitz, N. L., Lessov, C. N., Jacob, P., 3rd, Tyndale, R. F., & Wilhelmsen, K. (2005). Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence. Pharmacogenetics and Genomics, 15, 115-125.
19. Yamanaka, H., Nakajima, M., Katoh, M., Kanoh, A., Tamura, O., Ishibashi, H., & Yokoi, T. (2005). Trans-3′-hydroxycotinine O- and N-glucuronidations in human liver microsomes. Drug Metabolism and Disposition, 33, 23-30.